Unknown

Dataset Information

0

Diffusible, highly bioactive oligomers represent a critical minority of soluble A? in Alzheimer's disease brain.


ABSTRACT: Significant data suggest that soluble A? oligomers play an important role in Alzheimer's disease (AD), but there is great confusion over what exactly constitutes an A? oligomer and which oligomers are toxic. Most studies have utilized synthetic A? peptides, but the relevance of these test tube experiments to the conditions that prevail in AD is uncertain. A few groups have studied A? extracted from human brain, but they employed vigorous tissue homogenization which is likely to release insoluble A? that was sequestered in plaques during life. Several studies have found such extracts to possess disease-relevant activity and considerable efforts are being made to purify and better understand the forms of A? therein. Here, we compared the abundance of A? in AD extracts prepared by traditional homogenization versus using a far gentler extraction, and assessed their bioactivity via real-time imaging of iPSC-derived human neurons plus the sensitive functional assay of long-term potentiation. Surprisingly, the amount of A? retrieved by gentle extraction constituted only a small portion of that released by traditional homogenization, but this readily diffusible fraction retained all of the A?-dependent neurotoxic activity. Thus, the bulk of A? extractable from AD brain was innocuous, and only the small portion that was aqueously diffusible caused toxicity. This unexpected finding predicts that generic anti-oligomer therapies, including A? antibodies now in trials, may be bound up by the large pool of inactive oligomers, whereas agents that specifically target the small pool of diffusible, bioactive A? would be more useful. Furthermore, our results indicate that efforts to purify and target toxic A? must employ assays of disease-relevant activity. The approaches described here should enable these efforts, and may assist the study of other disease-associated aggregation-prone proteins.

SUBMITTER: Hong W 

PROVIDER: S-EPMC6647843 | biostudies-literature | 2018 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Diffusible, highly bioactive oligomers represent a critical minority of soluble Aβ in Alzheimer's disease brain.

Hong Wei W   Wang Zemin Z   Liu Wen W   O'Malley Tiernan T TT   Jin Ming M   Willem Michael M   Haass Christian C   Frosch Matthew P MP   Walsh Dominic M DM  

Acta neuropathologica 20180423 1


Significant data suggest that soluble Aβ oligomers play an important role in Alzheimer's disease (AD), but there is great confusion over what exactly constitutes an Aβ oligomer and which oligomers are toxic. Most studies have utilized synthetic Aβ peptides, but the relevance of these test tube experiments to the conditions that prevail in AD is uncertain. A few groups have studied Aβ extracted from human brain, but they employed vigorous tissue homogenization which is likely to release insoluble  ...[more]

Similar Datasets

| S-EPMC6916291 | biostudies-literature
| S-EPMC4443025 | biostudies-literature
| S-EPMC2789110 | biostudies-other
| S-EPMC3254782 | biostudies-literature
| S-EPMC8101010 | biostudies-literature